Spina Bifida Treatment Market
Spina Bifida Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Surgical Treatment, Pharmacological Treatment, Assistive & Supportive Care), By Type (Myelomeningocele, Meningocele, Spina Bifida Occulta), By End-User (Hospitals & Specialty Clinics, Rehabilitation Centers, Homecare Providers), By Technology Type (Open Fetal Surgery, Minimally Invasive Fetal Surgery (Fetoscopic), Conventional Neurosurgical Procedures, Advanced Rehabilitation Technologies (Robotics, Neurostimulation)), Forecast Period (2026-2035)
Industry Overview
Spina bifida treatment market size was valued at $1.88 billion in 2025 and is projected to reach $3.25 billion by 2035, growing at a CAGR of 5.62% between 2026 and 2035. The market comprises a range of surgical, pharmacological, and supportive treatment solutions aimed at managing spina bifida, a congenital neural tube defect affecting spinal cord development. A major growth driver is the increasing prevalence of congenital birth defects and rising awareness of early diagnosis and intervention. According to the World Health Organization, neural tube defects affect nearly 300,000 newborns globally each year, highlighting the significant demand for treatment solutions. Increasing healthcare investments and expansion of specialized paediatric care facilities are supporting market growth. Additionally, the U.S. Food and Drug Administration continues to support innovations in medical devices and surgical technologies, improving patient outcomes. The market is widely driven by hospitals, specialty clinics, and rehabilitation centers, which play a critical role in delivering long-term patient care and improving quality of life.
Market Dynamics
Rising Prevalence of Neural Tube Defects Driving Market Growth
The increasing incidence of neural tube defects is a major factor driving the spina bifida treatment market. According to the Centers for Disease Control and Prevention, approximately 1,500 to 2,000 babies are born with spina bifida annually in the United States. Additionally, the World Health Organization emphasizes the importance of folic acid supplementation and prenatal screening to reduce disease incidence. Growing awareness campaigns and government initiatives are improving early diagnosis and expanding treatment access globally. Between 2025 and 2026, companies are focusing on developing advanced surgical techniques and minimally invasive procedures to enhance patient outcomes. Strategic collaborations and product innovations in neurosurgical devices and rehabilitation technologies are further strengthening the market landscape.
High Treatment Costs and Long-Term Care Complexity Limiting Market Growth
Despite growing demand, the market faces challenges related to high treatment costs and long-term care requirements. Spina bifida treatment often involves multiple surgeries, lifelong medication, and continuous rehabilitation, increasing the financial burden on healthcare systems and patients. According to the Organisation for Economic Co-operation and Development, rising healthcare costs and resource constraints are impacting access to specialized treatments globally. Additionally, limited availability of skilled neurosurgeons and specialized rehabilitation centers in developing regions restricts market growth. To overcome these challenges, companies are investing in cost-effective treatment technologies and expanding healthcare infrastructure through partnerships and government collaborations.
Market Segmentation
- Based on the treatment type, the market is segmented into surgical treatment, pharmacological treatment, and assistive & supportive care.
- Based on the type, the market is segmented into myelomeningocele, meningocele, and spina bifida occulta.
- Based on the end-user, the market is segmented into hospitals & specialty clinics, rehabilitation centers, and homecare providers.
- Based on the technology type, the market is segmented into open fetal surgery, minimally invasive fetal surgery (fetoscopic), conventional neurosurgical procedures, and advanced rehabilitation technologies.
Surgical Treatment Segment Leads the Market
The surgical treatment segment holds a dominant position in the spina bifida treatment market due to its critical role in correcting spinal defects and preventing complications. Early surgical intervention is essential for improving neurological outcomes and reducing disability. Increasing adoption of advanced fetal surgery and postnatal procedures between 2022 and 2026 is driving segment growth. Companies are focusing on developing minimally invasive surgical tools and biologic grafts to enhance treatment success rates and reduce recovery time.
Minimally Invasive Fetal Surgery Segment to Record Strong Growth
The minimally invasive fetal surgery segment is expected to witness strong growth due to technological advancements in prenatal treatment techniques. These procedures offer reduced surgical risks, shorter recovery times, and improved outcomes compared to traditional open surgeries. Increasing investments in robotic-assisted surgery and imaging technologies are supporting segment expansion. The growing focus on early-stage intervention and improved prenatal diagnosis is further accelerating adoption.
Regional Outlook
The global spina bifida treatment market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
United States Leads the Market
The United States dominates the spina bifida treatment market due to advanced healthcare infrastructure and high healthcare expenditure. According to the Centers for Disease Control and Prevention, strong surveillance programs and early diagnosis initiatives are improving treatment outcomes. Continuous investments in neurosurgical technologies and rehabilitation services further strengthen market growth.
China to Record Strong Growth
China is expected to witness strong growth due to increasing healthcare investments and expanding medical infrastructure. According to the World Health Organization, improving maternal healthcare and prenatal screening programs are supporting early diagnosis. Rising government focus on rare disease treatment and healthcare accessibility is driving market expansion.
Competitive Landscape
The spina bifida treatment market is highly competitive, driven by innovation in surgical technologies and rehabilitation solutions. Leading companies such as Medtronic, Integra LifeSciences, B. Braun SE, Coloplast, and Boston Scientific are focusing on expanding product portfolios, enhancing technological capabilities, and strengthening global presence to maintain competitive advantage.
Recent Developments
- In April 2026, Integra LifeSciences Holdings Corporation presented new real-world clinical data on its PriMatrix® Dermal Scaffold across multiple major medical conferences, including the Functional Diabetic Limb Salvage Conference, SAWC/WHS Conference, and the American Burn Association Annual Meeting. The data, derived from 985 cases involving 117 surgeons, demonstrated the product’s effectiveness across diverse wound types, including surgical, traumatic, and chronic wounds, as well as complex cases. This initiative strengthens Integra’s clinical evidence base and supports the adoption of advanced dermal repair solutions in wound care and regenerative medicine applications.
- In March 2026, Medtronic received clearance from the U.S. Food and Drug Administration for its Stealth AXiS™ surgical system for cranial and ear, nose, and throat (ENT) procedures. The system integrates surgical planning, navigation, and robotics into a unified AI-enabled platform, enhancing precision and real-time decision-making in complex procedures. This development strengthens Medtronic’s neuroscience portfolio and supports the advancement of connected surgical technologies, improving procedural efficiency and patient outcomes across multiple specialties.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global spina bifida treatment market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
·
Current
Industry Analysis and Growth Potential Outlook
·
Global
Spina Bifida Treatment Market Sales Analysis – Treatment Type | Type | End-User
| Technology Type ($ Million)
·
Spina
Bifida Treatment Market Sales Performance of Top Countries
1.1 Research Methodology
·
Primary
Research Approach
·
Secondary
Research Approach
1.2 Market Snapshot
2. Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current
Market Trends
2.2.1 Key Spina Bifida Treatment
Market Trends
2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for
the Spina Bifida Treatment Market
2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes
3. Market Determinants
3.1 Market Drivers
3.1.1 Drivers For Global Spina Bifida
Treatment Market: Impact Analysis
3.2 Market Pain Points and Challenges
3.2.1 Restraints For Global Spina
Bifida Treatment Market: Impact Analysis
3.3 Market Opportunities
3.3.1 Opportunities For Global Spina
Bifida Treatment Market: Impact Analysis
4. Competitive Landscape
4.1 Competitive Dashboard – Spina
Bifida Treatment Market Revenue and Share by Manufacturers
·
Spina
Bifida Treatment Product Comparison Analysis
·
Top
Market Player Ranking Matrix
4.2 Key Company Analysis
4.2.1 Medtronic plc
4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy
4.2.2 Integra LifeSciences
4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy
4.2.3 B. Braun SE
4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy
4.2.4 Coloplast A/S
4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy
4.2.5 Boston Scientific Corporation
4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy
4.3 Top Winning Strategies by Market
Players
4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration
5. Global Spina Bifida Treatment
Market Sales Analysis by Treatment Type ($ Million)
5.1 Surgical Treatment
5.2 Pharmacological Treatment
5.3 Assistive & Supportive Care
6. Global Spina Bifida Treatment
Market Sales Analysis by Type ($ Million)
6.1 Myelomeningocele
6.2 Meningocele
6.3 Spina Bifida Occulta
7. Global Spina Bifida Treatment
Market Sales Analysis by End-User ($ Million)
7.1 Hospitals & Specialty Clinics
7.2 Rehabilitation Centers
7.3 Homecare Providers
8. Global Spina Bifida Treatment
Market Sales Analysis by Technology Type ($ Million)
8.1 Open Fetal Surgery
8.2 Minimally Invasive Fetal Surgery (Fetoscopic)
8.3 Conventional Neurosurgical Procedures
8.4 Advanced Rehabilitation Technologies (Robotics, Neurostimulation)
9. Regional Analysis
9.1 North American Spina Bifida
Treatment Market Sales Analysis – Treatment Type | Type | End-User | Technology
Type ($ Million)
9.1.1 United States
9.1.2 Canada
9.2 European Spina Bifida Treatment
Market Sales Analysis – Treatment Type | Type | End-User | Technology Type ($
Million)
9.2.1 UK
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 France
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia-Pacific Spina Bifida
Treatment Market Sales Analysis – Treatment Type | Type | End-User | Technology
Type ($ Million)
9.3.1 China
9.3.2 Japan
9.3.3 South Korea
9.3.4 India
9.3.5 Australia & New Zealand
9.3.6 ASEAN Countries
9.3.7 Rest of Asia-Pacific
9.4 Rest of the World Spina Bifida
Treatment Market Sales Analysis – Treatment Type | Type | End-User | Technology
Type ($ Million)
9.4.1 Latin America
9.4.2 Middle East and Africa
10. Company Profiles
10.1 AbbVie Inc.
10.1.1 Quick Facts
10.1.2 Company Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.2 Astellas Pharma Inc.
10.2.1 Quick Facts
10.2.2 Company Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.3 Becton, Dickinson and Company
10.3.1 Quick Facts
10.3.2 Company Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.4 Convatec Group PLC
10.4.1 Quick Facts
10.4.2 Company Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.5 Cook Medical
10.5.1 Quick Facts
10.5.2 Company Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.6 Hollister Incorporated
10.6.1 Quick Facts
10.6.2 Company Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.7 InnovaMedical
10.7.1 Quick Facts
10.7.2 Company Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.8 Johnson & Johnson Medtech
10.8.1 Quick Facts
10.8.2 Company Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.9 Karl Storz SE & Co. KG
10.9.1 Quick Facts
10.9.2 Company Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.10 Minerva Health Solutions
10.10.1 Quick Facts
10.10.2 Company Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.11 Natus Medical Incorporated
10.11.1 Quick Facts
10.11.2 Company Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.12 Olympus Corporation
10.12.1 Quick Facts
10.12.2 Company Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.13 Ottobock SE & Co. KGaA
10.13.1 Quick Facts
10.13.2 Company Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.14 Permobil
10.14.1 Quick Facts
10.14.2 Company Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.15 Sophysa
10.15.1 Quick Facts
10.15.2 Company Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.16 Stryker Corporation
10.16.1 Quick Facts
10.16.2 Company Overview
10.16.3 Product Portfolio
10.16.4 Business Strategies
10.17 Sunrise Medical
10.17.1 Quick Facts
10.17.2 Company Overview
10.17.3 Product Portfolio
10.17.4 Business Strategies
10.18 Teleflex Incorporated
10.18.1 Quick Facts
10.18.2 Company Overview
10.18.3 Product Portfolio
10.18.4 Business Strategies
10.19 Viatris Inc.
10.19.1 Quick Facts
10.19.2 Company Overview
10.19.3 Product Portfolio
10.19.4 Business Strategies
10.20 Wellspect HealthCare
10.20.1 Quick Facts
10.20.2 Company Overview
10.20.3 Product Portfolio
10.20.4 Business Strategies
1. Global Spina Bifida Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
2. Global Surgical Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Pharmacological Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Assistive & Supportive Care Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Spina Bifida Treatment Market Research and Analysis by Type, 2025–2035 ($ Million)
6. Global Myelomeningocele Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Meningocele Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Spina Bifida Occulta Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Spina Bifida Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million)
10. Global Spina Bifida Treatment for Hospitals & Specialty Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Spina Bifida Treatment for Rehabilitation Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Spina Bifida Treatment for Homecare Providers Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Spina Bifida Treatment Market Research and Analysis by Technology Type, 2025–2035 ($ Million)
14. Global Open Fetal Surgery Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Minimally Invasive Fetal Surgery Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Conventional Neurosurgical Procedures Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Advanced Rehabilitation Technologies Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
19. North America Spina Bifida Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
20. North America Spina Bifida Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
21. North America Spina Bifida Treatment Market Research and Analysis by Type, 2025–2035 ($ Million)
22. North America Spina Bifida Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million)
23. North America Spina Bifida Treatment Market Research and Analysis by Technology Type, 2025–2035 ($ Million)
24. Europe Spina Bifida Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
25. Europe Spina Bifida Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
26. Europe Spina Bifida Treatment Market Research and Analysis by Type, 2025–2035 ($ Million)
27. Europe Spina Bifida Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million)
28. Europe Spina Bifida Treatment Market Research and Analysis by Technology Type, 2025–2035 ($ Million)
29. Asia-Pacific Spina Bifida Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
30. Asia-Pacific Spina Bifida Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
31. Asia-Pacific Spina Bifida Treatment Market Research and Analysis by Type, 2025–2035 ($ Million)
32. Asia-Pacific Spina Bifida Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million)
33. Asia-Pacific Spina Bifida Treatment Market Research and Analysis by Technology Type, 2025–2035 ($ Million)
34. Rest of the World Spina Bifida Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
35. Rest of the World Spina Bifida Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
36. Rest of the World Spina Bifida Treatment Market Research and Analysis by Type, 2025–2035 ($ Million)
37. Rest of the World Spina Bifida Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million)
38. Rest of the World Spina Bifida Treatment Market Research and Analysis by Technology Type, 2025–2035 ($ Million)
1. Global Spina Bifida Treatment Market Share by Treatment Type, 2025 Vs 2035 (%)
2. Global Surgical Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
3. Global Pharmacological Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
4. Global Assistive & Supportive Care Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
5. Global Spina Bifida Treatment Market Share by Type, 2025 Vs 2035 (%)
6. Global Myelomeningocele Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
7. Global Meningocele Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
8. Global Spina Bifida Occulta Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
9. Global Spina Bifida Treatment Market Share by End-User, 2025 Vs 2035 (%)
10. Global Spina Bifida Treatment for Hospitals & Specialty Clinics Share by Region, 2025 Vs 2035 (%)
11. Global Spina Bifida Treatment for Rehabilitation Centers Share by Region, 2025 Vs 2035 (%)
12. Global Spina Bifida Treatment for Homecare Providers Share by Region, 2025 Vs 2035 (%)
13. Global Spina Bifida Treatment Market Share by Technology Type, 2025 Vs 2035 (%)
14. Global Open Fetal Surgery Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
15. Global Minimally Invasive Fetal Surgery Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
16. Global Conventional Neurosurgical Procedures Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
17. Global Advanced Rehabilitation Technologies Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
18. Global Spina Bifida Treatment Market Share by Region, 2025 Vs 2035 (%)
19. US Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
20. Canada Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
21. UK Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
22. France Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
23. Germany Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
24. Italy Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
25. Spain Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
26. Russia Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
27. India Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
28. China Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
29. Japan Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
30. South Korea Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
31. Australia & New Zealand Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
32. ASEAN Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
33. Rest of Asia-Pacific Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
34. Latin America Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
35. Middle East & Africa Spina Bifida Treatment Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
